Venture Certified
| 연구개발유형 | 2024-05-22 ~ 2027-05-21 | 20240522020002 | 2024-05-22 |
| Item | 2024 | 2023 |
|---|---|---|
| Revenue | 0.2B | 0.0B |
| Operating Profit | -5.8B | -3.6B |
| Net Profit | -5.8B | -3.6B |
| Total Assets | 2.9B | 1.9B |
| Total Liabilities | 3.3B | 0.5B |
| Total Equity | -0.4B | 1.4B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Operating Loss: Op. profit -6B
2 Consecutive Years of Net Loss
▲ 0.0%
▼ 59.2%
▼ 2418.3%
▲ 654.9%
| Name | Position | Role |
|---|---|---|
| 홍진만 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기도 성남시",
"ceo_name": "홍진만",
"certificate": [
{
"cert_number": "20240522020002",
"changes": "",
"disclosure_date": "2024-05-22",
"first_cert_date": "2024-05-22",
"no": "1",
"type": "연구개발유형",
"valid_period": "2024-05-22 ~ 2027-05-21"
}
],
"company_name": "포도테라퓨틱스 주식회사",
"corp_no": "131111-*******",
"financials": {
"2023": {
"capital_stock": 500000000,
"cost_of_sales": 0,
"current_assets": 143746000,
"current_liabilities": 48720000,
"gross_profit": 0,
"net_income": -361715000,
"net_income_bs": -361715000,
"non_current_assets": 43259000,
"non_current_liabilities": 0,
"non_operating_expenses": 0,
"non_operating_income": 363000,
"operating_profit": -362078000,
"revenue": 0,
"sga_expenses": 362078000,
"total_assets": 187005000,
"total_equity": 138285000,
"total_liabilities": 48720000
},
"2024": {
"capital_stock": 566667000,
"cost_of_sales": 0,
"current_assets": 201217000,
"current_liabilities": 325343000,
"gross_profit": 15200000,
"net_income": -578120000,
"net_income_bs": -578120000,
"non_current_assets": 84293000,
"non_current_liabilities": 0,
"non_operating_expenses": 1853000,
"non_operating_income": 179000,
"operating_profit": -576446000,
"revenue": 15200000,
"sga_expenses": 591646000,
"total_assets": 285510000,
"total_equity": -39833000,
"total_liabilities": 325343000
}
},
"industry": "의학 및 약학 연구개발업",
"investment": [],
"main_products": "오가노이드 기반 정밀의료 및 동반진단기술",
"phone": "031-707-****",
"years": [
2024,
2023
]
}Data Quality: 7/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |